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that the molecules must interact with only a minimalFinding Their Groove: Bifunctional
number of binding sites within the genome in order toMolecules Arrest Growth avoid affecting numerous biological processes. The
most common approach taken to develop transcrip-of Cancer Cells
tional inhibitors relies upon designing a molecule to tar-
get a specific DNA binding site associated with the gene
of interest. The designed molecule is then tested first
In this issue, Dickinson et al. describe an exciting ad- in vitro and subsequently in cell culture. However, it is
vance in the search for inhibitors of transcription that often difficult to predict the behavior of the molecule in
function well in cells [1]. The authors screen for small the complex environment of the cell based upon in vitro
molecules that selectively damage DNA and identify results due to issues of cell and nuclear permeability as
a histone gene as a potential new target for cancer well as the accessibility of the cognate DNA binding
therapeutic development. sites in the context of chromatin.
The approach taken by Gottesfeld and Dervan in this
issue of Chemistry & Biology circumvents some of theMany human diseases exhibit altered patterns of gene
difficulties outlined above and represents a departuretranscription [2–4]. Overexpression of the human tran-
from the typical mechanism of transcriptional inhibitorscriptional inhibitor Mdm2, for example, has been corre-
discovery [1]. Instead, the authors synthesized a smalllated with a number of human cancers [5–7]. These al-
group of molecules and screened for activity in humantered patterns are a signature of a particular disease,
colon cancer cells before investigating the origin of thethey are useful for characterization and diagnosis, and
observed effects. The molecules themselves are bifunc-they further offer an opportunity for targeting therapies
tional, containing a sequence-specific DNA bindingspecifically to diseased cells. One exciting approach is
module and a functional group that damages DNA (Fig-to home in on the affected genes themselves and inter-
ure 1). The DNA binding module is a hairpin polyamide,rupt or promote their transcription by using molecules
a minor groove binding agent composed largely of het-that interact with specific DNA sequences [8–11]. So, for
erocyclic amino acids that mediate sequence-specificexample, a triplex-forming oligonucleotide that prevents
interactions with the functional groups present in thethe transcription factor Sp1 from binding to DNA effec-
minor groove. The mode of binding for hairpin polyam-tively inhibits the transcription of the Src1 gene regu-
ides is such that pairs of heterocycles bind side-by-sidelated by that protein in cell culture [12]. Among the his-
in the minor groove recognizing a specific base pair intoric difficulties with identifying small molecules that can
a predictable manner—G•C versus C•G, for example—accomplish this task is that such molecules must not
and it is thus possible to design a structure that recognizesonly be cell and nuclear permeable but also must com-
a particular sequence. The authors prepared five polyam-pete for DNA binding sites with a wide range of proteins
in order to exert their function. An additional hurdle is ide-based structures for screening, each with a distinct
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Figure 1. Two of the Five Polyamide-Chlor-
ambucil Conjugates Prepared for the Study
The DNA sequence preference for each struc-
ture is indicated.
sequence preference. Interestingly, none of the five struc- tones in cell cycle progression, it is not surprising that
downregulation of this gene would affect cell growthtures are designed to recognize a unique sequence within
genomic DNA; each has a target binding site size of 6–7 [17]. There were thus two key questions at this stage: (1)
does downregulation of H4c contribute to the observedbase pairs, and within that sequence, 3–5 positions can
be either an A•T or a T•A base pair. Thus, thousands cellular changes?; and (2) is the downregulation a result
of conjugate 1 binding and damaging DNA somewhereof binding sites for the molecules exist in every cell.
Although hairpin polyamides interact with their cog- within that gene? The authors provide compelling evi-
dence supporting affirmative answers to both of thesenate DNA sites with high affinity and have been shown
to compete with some DNA binding proteins for their questions. In the first case, downregulation of H4c gene
transcription by an alternative mechanism, siRNA, pro-cognate sites, polyamides provide no impediment to
the polymerase machineries that transcribe or replicate duced similar changes in the appearance and growth
of human colon cancer cells to those observed in theDNA [11]. Thus, the authors included an additional func-
tional group in their design: an alkylating agent that presence of compound 1. Future experiments compar-
ing the transcript levels of all genes from cells containingcrosslinks the polyamide to DNA. They chose for this
purpose the well-characterized DNA damage agent the H4c-specific siRNA with the levels found upon treat-
ment of cells with 1 will provide additional insight intochlorambucil, a cancer therapeutic [13]. Conjugation of
chlorambucil to a sequence-specific DNA binding mole- this question. Toward the second question, the authors
identified four potential binding sites for 1 within thecule imposes the DNA binding specificity onto the DNA
damage agent, and in the case of polyamides, this leads coding region of the H4c gene and used ligation-medi-
ated PCR to demonstrate that one of those sites isto alkylation of purine residues proximal to the DNA
binding site [14]. In a recent pioneering study also ap- specifically alkylated by 1 in cell culture. Extending the
cell-based results to animal studies, the authors foundpearing in Chemistry & Biology, Dervan and Gottesfeld
demonstrated that polyamide-chlorambucil conjugates that conjugate 1 inhibits tumor growth in mice, either
upon dosing the animals with 1 or by pretreatment ofcan localize in the nuclei of live cells and alkylate chro-
matin bound DNA at sites determined by the binding the tumor cells with the molecule, a remarkable finding.
As a result, the H4c gene is an exciting new target forspecificity of the polyamide moiety [15, 16].
Of the groups of human colon cancer cells treated the development of antiproliferative agents.
It is not surprising that a hybrid molecule such as 1with the five polyamide-chlorambucil conjugates exam-
ined in this study, only cells treated with 1 showed signif- with both DNA binding and DNA damaging capabilities
impacts cell growth, but the mechanism by which thisicant morphological changes and growth arrest largely
unaccompanied by cell death; less specific conjugates occurs is an exciting and thought-provoking finding.
The H4c gene is ubiquitous in human cells, yet it issuch as 2 exhibited high cytotoxicity that is presumably
related to extensive DNA alkylation. By examining the overexpressed in only a subset of cell types, including
the colon cancer cells examined in this study. In fact,transcription levels of approximately 18,000 genes in
cells either treated with 1 or with one of several controls, the transcript analysis described in this work showed
that the H4c gene accounted for fully 70% of the totalthe authors found that 77 genes were upregulated and
35 were downregulated after treatment with 1. Remark- H4 mRNA. Further, as discussed by the authors, it is
likely that the transcriptionally active state of this geneably, only a single gene, H4c, was downregulated more
than 2-fold. H4c is one of several genes encoding the is what allows conjugate 1 to specifically target H4c
relative to the many other H4-coding genes that containhistone protein H4, and due to the central role of his-
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